Biologics Manufacturing in Uncertain Times : Strategies to Accelerate Your Pipeline and De-risk Your Supply Chain

Kemwell Biopharma, in collaboration with EPPIC Global and Bioprocess AI, invites bay area biologics manufacturing leaders, innovators, and CMC experts to an engaging in-person event focused on strategies to accelerate pipeline development, and de-risk the supply chain in uncertain times. This high-impact session will discuss real-world case studies, expert perspectives, and technology spotlights designed to accelerate innovation while managing risk. Kemwell Biopharma will showcase a case study demonstrating how it achieved tech transfer to drug product within six months for a U.S. biotech utilizing its fully integrated, single-site facility that streamlines end-to-end drug substance (DS) and drug product (DP) manufacturing.